Form 4: Pfizer CEO Bourla Reports Phantom Stock Unit Acquisition

Pfizer Chairman & CEO Albert Bourla acquired 25 phantom stock units under a deferred compensation plan on June 30, 2026.

Summary

• Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 25 phantom stock units on June 30, 2026.
• These units were acquired under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
• Each unit represents one phantom share of common stock.
• The units are settled in cash upon the reporting person's separation from service.
• Bourla can transfer these units into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive compensation transaction rather than a significant strategic or financial event.

Positives

• The acquisition of phantom stock units indicates continued participation in company incentive plans by the CEO.
• The plan allows for flexibility in managing these units, including transfer to alternative investment accounts.

Risks

• The value of the phantom stock units is tied to the performance of Pfizer's common stock, thus subject to market volatility.
• Settlement in cash upon separation from service means the ultimate value realization depends on future events and company performance at that time.

Future Outlook

The filing does not contain forward-looking statements or guidance. The phantom stock units are settled in cash following the reporting person's separation from service.

Industry Context

StockSavvy.ai notes that the acquisition of phantom stock units by a CEO is a common practice in the pharmaceutical industry as part of executive compensation and retention strategies, aligning management interests with long-term company performance.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact share price but reflects executive compensation practices.
• Employees: The plan is part of a broader compensation structure for executives.
• Management: Reinforces the CEO's participation in long-term incentive plans.

Next Steps

• Settlement of phantom stock units in cash upon reporting person's separation from service.
• Potential transfer of units by the reporting person into an alternative investment account.

Key Dates

Keywords

Pfizer, PFE, Albert Bourla, Form 4, Insider Trading, Phantom Stock Units, Deferred Compensation, Executive Compensation, SEC Filing